Loughrey J P R, Walsh F, Gardiner J
Department of Anesthesia, Rotunda Hospital, Dublin, Ireland.
Eur J Anaesthesiol. 2002 Jan;19(1):63-8. doi: 10.1017/s0265021502000108.
To evaluate the efficacy and optimal dose of prophylactic intravenous ephedrine for the prevention of maternal hypotension associated with spinal anaesthesia for Caesarean section.
After patients had received an intravenous preload of 0.5 L of lactated Ringer's solution, spinal anaesthesia was administered in the sitting position with hyperbaric bupivacaine 2.5 mL 0.5% combined with 25 microg fentanyl. A total of 68 patients were randomized to receive a simultaneous 2 mL bolus intravenously of either 0.9% saline (Group C, n = 20), ephedrine 6 mg (Group E-6, n = 24), or ephedrine 12 mg (Group E-12, n = 22). Further rescue boluses of ephedrine 6 mg were given if systolic arterial pressure fell to below 90 mmHg, greater than 30% below baseline, or if symptoms suggestive of hypotension were reported.
There was a significantly higher incidence of hypotension in Group C (60% patients) compared to Group E-12 (27%), but not in Group E-6 (50%). The 95% Confidence Interval for the difference in proportions between Groups C and E-12 was 6-60%, P < 0.05. Fewer rescue boluses of ephedrine were required in Group E-12 compared with Group C (1.8 +/- 1.2 vs. 3.3 +/- 2.1, P < 0.05). There were no significant differences in the incidence of maternal nausea or vomiting, or of neonatal acidaemia between groups.
A prophylactic bolus of ephedrine 12 mg intravenously given at the time of intrathecal block, plus rescue boluses, leads to a lower incidence of hypotension following spinal anaesthesia for elective Caesarean section compared to intravenous rescue boluses alone.
评估预防性静脉注射麻黄碱预防剖宫产脊髓麻醉相关产妇低血压的疗效及最佳剂量。
患者静脉输注0.5 L乳酸林格氏液进行预负荷后,取坐位行脊髓麻醉,使用2.5 mL 0.5%的重比重布比卡因联合25 μg芬太尼。共68例患者随机分为3组,分别静脉推注2 mL的0.9%生理盐水(C组,n = 20)、6 mg麻黄碱(E-6组,n = 24)或12 mg麻黄碱(E-12组,n = 22)。若收缩压降至90 mmHg以下(较基线降低超过30%)或出现低血压相关症状,则给予6 mg麻黄碱进行进一步抢救推注。
与E-12组(27%)相比,C组低血压发生率显著更高(60%患者),但E-6组(50%)并非如此。C组与E-12组比例差异的95%置信区间为6%-60%,P < 0.05。与C组相比,E-12组所需麻黄碱抢救推注次数更少(1.8±1.2次对3.3±2.1次,P < 0.05)。各组间产妇恶心或呕吐发生率以及新生儿酸血症发生率无显著差异。
与单纯静脉注射抢救推注相比,在鞘内阻滞时静脉预防性推注12 mg麻黄碱加抢救推注,可使择期剖宫产脊髓麻醉后低血压发生率降低。